Catherine Fagard

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).

Journal: The Journal of antimicrobial chemotherapy

Published: September 11, 2017

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.

Journal: The lancet. HIV

Published: April 07, 2017

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.

Journal: The Journal of antimicrobial chemotherapy

Published: June 02, 2016

Tropism distribution among antiretroviral-naive HIV-2-infected patients.

Tropism distribution among antiretroviral-naive HIV-2-infected patients.

Journal: AIDS (London, England)

Published: November 07, 2015

Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.

Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.

Journal: The Journal of antimicrobial chemotherapy

Published: September 17, 2015

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Journal: The Journal of antimicrobial chemotherapy

Published: August 06, 2015

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).

Journal: The Journal of antimicrobial chemotherapy

Published: July 02, 2015

Recent developments in clinical trial designs for HIV vaccine research.

Recent developments in clinical trial designs for HIV vaccine research.

Journal: Human vaccines & immunotherapeutics

Published: March 10, 2015

Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy.

Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 09, 2015

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.

Journal: The Journal of antimicrobial chemotherapy

Published: November 07, 2014

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.

Journal: AIDS (London, England)

Published: September 30, 2014

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.

Journal: The Lancet. Infectious diseases

Published: April 15, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026